Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Mankoff

Showing results (141-150 of 244) with videos related to

Pageof 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlationLaurie L Carr, David A Mankoff, Bernardo H Goulart, et al.
Tomography (Ann Arbor, Mich.)|January 26, 2016
Effect of <sup>18</sup>F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancerKristen A Wangerin, Mark Muzi, Lanell M Peterson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2021
Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
Cancer Research Communications|January 13, 2025
Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with Proliferation and Early RecurrenceElizabeth S McDonald, Tien-Chi Pan, Dhruv K Pant, et al.
Molecular Imaging|August 19, 2003
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient resultsJoanne M Wells, David A Mankoff, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiolLanell M Peterson, David A Mankoff, Thomas Lawton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
Differential Response to <sup>177</sup>Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate CancerAbigail Pepin, Abigail Doucette, Vivek K Narayan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2002
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapyDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Nuclear Medicine and Biology|October 17, 2002
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flowDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Pageof 25

Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2010
Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlationLaurie L Carr, David A Mankoff, Bernardo H Goulart, et al.
Tomography (Ann Arbor, Mich.)|January 26, 2016
Effect of <sup>18</sup>F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancerKristen A Wangerin, Mark Muzi, Lanell M Peterson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2021
Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancerRhea Chitalia, Varsha Viswanath, Austin R Pantel, et al.
Cancer Research Communications|January 13, 2025
Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with Proliferation and Early RecurrenceElizabeth S McDonald, Tien-Chi Pan, Dhruv K Pant, et al.
Molecular Imaging|August 19, 2003
Kinetic analysis of 2-[11C]thymidine PET imaging studies of malignant brain tumors: preliminary patient resultsJoanne M Wells, David A Mankoff, Janet F Eary, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiolLanell M Peterson, David A Mankoff, Thomas Lawton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
Differential Response to <sup>177</sup>Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate CancerAbigail Pepin, Abigail Doucette, Vivek K Narayan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2002
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapyDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Nuclear Medicine and Biology|October 17, 2002
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flowDavid A Mankoff, Lisa K Dunnwald, Julie R Gralow, et al.
Pageof 25